News

People who took Zepbound had greater reductions in waist circumference and body weight, a study found.Fact checked by Nick ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.
Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to ...
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
The price of weight loss drugs is falling. Wegovy and Zepbound, which both sell for a list price of more than $1,000 a month, have long been out of reach for people without insurance or whose ...